BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35802768)

  • 1. Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
    Yu G; Corn PG; Shen P; Song JH; Lee YC; Lin SC; Pan J; Agarwal SK; Panaretakis T; Pacifici M; Logothetis CJ; Yu-Lee LY; Lin SH
    Cancer Res; 2022 Sep; 82(17):3158-3171. PubMed ID: 35802768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RARγ: The Bone of Contention for Endothelial Cells in Prostate Cancer Metastasis.
    Bhowmick S; Bhowmick NA
    Cancer Res; 2022 Sep; 82(17):2975-2976. PubMed ID: 36052494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial-to-osteoblast transition in normal mouse bone development.
    Lin SC; Yu G; Lee YC; Song JH; Song X; Zhang J; Panaretakis T; Logothetis CJ; Komatsu Y; Yu-Lee LY; Wang G; Lin SH
    iScience; 2023 Feb; 26(2):105994. PubMed ID: 36798441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition.
    Lee YC; Lin SC; Yu G; Zhu M; Song JH; Rivera K; Pappin DJ; Logothetis CJ; Panaretakis T; Wang G; Yu-Lee LY; Lin SH
    Oncogene; 2022 Feb; 41(6):757-769. PubMed ID: 34845375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4.
    Yu G; Shen P; Lee YC; Pan J; Song JH; Pan T; Lin SC; Liang X; Wang G; Panaretakis T; Logothetis CJ; Gallick GE; Yu-Lee LY; Lin SH
    iScience; 2021 Apr; 24(4):102388. PubMed ID: 33981975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblastic Factors in Prostate Cancer Bone Metastasis.
    Lin SC; Yu-Lee LY; Lin SH
    Curr Osteoporos Rep; 2018 Dec; 16(6):642-647. PubMed ID: 30203251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.
    Lin SC; Lee YC; Yu G; Cheng CJ; Zhou X; Chu K; Murshed M; Le NT; Baseler L; Abe JI; Fujiwara K; deCrombrugghe B; Logothetis CJ; Gallick GE; Yu-Lee LY; Maity SN; Lin SH
    Dev Cell; 2017 Jun; 41(5):467-480.e3. PubMed ID: 28586644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid receptor signalling directly regulates osteoblast and adipocyte differentiation from mesenchymal progenitor cells.
    Green AC; Kocovski P; Jovic T; Walia MK; Chandraratna RAS; Martin TJ; Baker EK; Purton LE
    Exp Cell Res; 2017 Jan; 350(1):284-297. PubMed ID: 27964926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment.
    Yu G; Corn PG; Mak CSL; Liang X; Zhang M; Troncoso P; Song JH; Lin SC; Song X; Liu J; Zhang J; Logothetis CJ; Melancon MP; Panaretakis T; Wang G; Lin SH
    bioRxiv; 2023 Dec; ():. PubMed ID: 38076845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers.
    Idres N; Marill J; Flexor MA; Chabot GG
    J Biol Chem; 2002 Aug; 277(35):31491-8. PubMed ID: 12070176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report.
    Singh S; Kidane J; Wentworth KL; Motamedi D; Morshed S; Schober AE; Hsiao EC
    BMC Musculoskelet Disord; 2020 Apr; 21(1):204. PubMed ID: 32245464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer.
    Petrie K; Urban-Wójciuk Z; Sbirkov Y; Graham A; Hamann A; Brown G
    Cancer Rep (Hoboken); 2020 Dec; 3(6):e1284. PubMed ID: 32881426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Agonists of Nuclear Retinoic Acid Receptor Gamma Inhibit Growth of HCS-2/8 Chondrosarcoma Cells.
    Shield WP; Cellini A; Tian H; Wilson K; Dan Y; Abzug JM; Garcia S; Moritani N; Alferiev I; Chorny M; Takigawa M; Ng VY; Iwamoto M; Enomoto-Iwamoto M
    J Orthop Res; 2020 May; 38(5):1045-1051. PubMed ID: 31808569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.
    Hammond LA; Van Krinks CH; Durham J; Tomkins SE; Burnett RD; Jones EL; Chandraratna RA; Brown G
    Br J Cancer; 2001 Aug; 85(3):453-62. PubMed ID: 11487280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
    J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RARγ-C-Fos-PPARγ2 signaling rather than ROS generation is critical for all-trans retinoic acid-inhibited adipocyte differentiation.
    Wang X; Yang P; Liu J; Wu H; Yu W; Zhang T; Fu H; Liu Y; Hai C
    Biochimie; 2014 Nov; 106():121-30. PubMed ID: 25173565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation.
    Kirchmeyer M; Koufany M; Sebillaud S; Netter P; Jouzeau JY; Bianchi A
    Arthritis Res Ther; 2008; 10(6):R141. PubMed ID: 19068145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palovarotene: First Approval.
    Hoy SM
    Drugs; 2022 Apr; 82(6):711-716. PubMed ID: 35384641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling.
    Saito A; Sugawara A; Uruno A; Kudo M; Kagechika H; Sato Y; Owada Y; Kondo H; Sato M; Kurabayashi M; Imaizumi M; Tsuchiya S; Ito S
    Endocrinology; 2007 Mar; 148(3):1412-23. PubMed ID: 17170094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid receptor α mediates all-trans-retinoic acid-induced Klf4 gene expression by regulating Klf4 promoter activity in vascular smooth muscle cells.
    Shi JH; Zheng B; Chen S; Ma GY; Wen JK
    J Biol Chem; 2012 Mar; 287(14):10799-811. PubMed ID: 22337869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.